SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...

Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...

Ruanne Barnabas grew up in Durban, South Africa, during a time of “deep inequity in health, opportunity, and justice”.

At the Bronx Museum of the Arts, the sculptor’s first solo museum show, filled with autobiographical and religion-influenced ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

For 11 FDA-approved checkpoint inhibitors, we studied quarterly average sales prices from public Medicare spending files from Q3 2015 to Q1 2024; prices were standardized to cost per 28-day treatment ...

In an article published in The Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin Yiannoutsos aim to provide the most comprehensive estimates of pediatric ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) to be held in Paris, France from October 15-18. As the leader in HIV ...